Edition:
United Kingdom

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.00CNY
12 Dec 2017
Change (% chg)

¥-0.10 (-1.41%)
Prev Close
¥7.10
Open
¥7.13
Day's High
¥7.13
Day's Low
¥7.00
Volume
6,142,696
Avg. Vol
13,306,546
52-wk High
¥8.00
52-wk Low
¥6.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1,243.59 0.078
Mar '17 1,096.73 0.075
FY 2016 Dec '16 1,482.88 -0.004
Sep '16 1,487.53 0.057
Jun '16 1,572.75 0.061
Mar '16 1,477.22 0.061
FY 2015 Dec '15 1,554.12 -0.070
Sep '15 1,536.46 0.070
Jun '15 1,314.56 0.125
Mar '15 896.83 0.061
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 34.23 31.14 32.93
P/E High - Last 5 Yrs. 47.71 40.91 45.62
P/E Low - Last 5 Yrs. 26.54 23.80 24.34
Beta 0.94 0.90 0.88
Price to Sales (TTM) 3.34 3.93 5.40
Price to Book (MRQ) 4.05 4.81 5.38
Price to Tangible Book (MRQ) 5.91 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 1.70 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate 15.33 4.33 5.17
Payout Ratio(TTM) 58.10 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -20.93 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -13.51 4.66 5.38
Sales - 5 Yr. Growth Rate 21.65 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.12 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 68.58 -- --
EPS - 5 Yr. Growth Rate 1.43 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 9.08 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.13 2.11 2.18
Current Ratio (MRQ) 1.46 2.88 2.98
LT Debt to Equity (MRQ) 25.16 9.47 11.56
Total Debt to Equity (MRQ) 52.38 13.43 15.81
Interest Coverage (TTM) 1.40 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 56.24 55.14 54.83
Gross Margin - 5 Yr. Avg. 58.28 52.29 52.40
EBITD Margin (TTM) 16.08 -- --
EBITD - 5 Yr. Avg 17.88 18.46 15.24
Operating Margin (TTM) 11.27 14.50 7.76
Operating Margin - 5 Yr. Avg. 13.10 14.42 10.75
Pre-Tax Margin (TTM) 11.87 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 14.40 14.74 11.17
Net Profit Margin (TTM) 9.32 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 11.83 11.08 7.47
Effective Tax Rate (TTM) 21.45 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 17.81 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 615,237 953,213,833 864,673,366
Net Income/Employee (TTM) 57,352 112,151,384 101,717,513
Receivable Turnover (TTM) 5.57 5.60 5.76
Inventory Turnover (TTM) 2.69 2.58 3.34
Asset Turnover (TTM) 0.63 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.83 11.42 11.00
Return on Assets - 5 Yr. Avg. 7.93 13.00 12.43
Return on Investment (TTM) 9.47 14.86 14.46
Return on Investment - 5 Yr. Avg. 13.01 17.00 16.28
Return on Equity (TTM) 11.97 16.28 16.05
Return on Equity - 5 Yr. Avg. 14.95 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 13.55 27.22 21.65
EPS (TTM) % -5.89 -4.58 1.43
Dividend % 79.99 24.12 15.33
Note: Units in Millions of US Dollars

Performance for Zhejiang CONBA Pharmaceutical Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.43%
# of Holders: 49
Total Shares Held: 211,549,032
3 Mo. Net Change: 3,884,100
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.